Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30625
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFernandez, Monique-
dc.contributor.authorLokan, Julie-
dc.contributor.authorLeung, Christopher-
dc.contributor.authorGrigg, Andrew P-
dc.date2022-
dc.date.accessioned2022-08-02T06:42:30Z-
dc.date.available2022-08-02T06:42:30Z-
dc.date.issued2022-07-29-
dc.identifier.citationJournal of Gastroenterology and Hepatology 2022; 37(10): 1873-1883en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30625-
dc.description.abstractNon-alcoholic fatty liver disease (NAFLD) has been associated with a condition known as the dysmetabolic iron overload syndrome (DIOS), but the frequency and severity of iron overload in NAFLD is not well described. There is emerging evidence that mild to moderate excess hepatic iron can aggravate the risk of progression of NAFLD to non-alcoholic steatohepatitis (NASH) and eventually cirrhosis. Mechanisms are postulated to be via reactive oxygen species, inflammatory cytokines, lipid oxidation and oxidative stress. The aim of this review is to assess the evidence for true hepatic iron overload in NAFLD, discuss the pathogenesis by which excess iron may be toxic and to critically evaluate the studies designed to deplete iron by regular venesection. In brief, the studies are inconclusive due to heterogeneity in eligibility criteria, sample size, randomisation, hepatic iron measurement, serial histological endpoints, target ferritin levels, length of venesection and degree of confounding lifestyle intervention. We propose a trial designed to overcome the limitations of these studies.en
dc.language.isoeng-
dc.titleA critical evaluation of the role of iron overload in fatty liver disease.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of gastroenterology and hepatologyen
dc.identifier.affiliationAnatomical Pathology..en
dc.identifier.affiliationGastroenterology and Hepatology..en
dc.identifier.affiliationClinical Haematology..en
dc.identifier.affiliationDepartment of Medicine, the University of Melbourne, Parkville, Victoria, Australia..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35906772/en
dc.identifier.doi10.1111/jgh.15971en
dc.type.contentTexten
dc.identifier.orcid0000-0002-5110-7559en
dc.identifier.orcid0000-0002-1333-4734en
dc.identifier.orcid0000-0001-5743-3171en
dc.identifier.pubmedid35906772-
local.name.researcherGrigg, Andrew P
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptUniversity of Melbourne Clinical School-
crisitem.author.deptClinical Education-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptOlivia Newton-John Cancer Wellness and Research Centre-
crisitem.author.deptClinical Haematology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

40
checked on Jul 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.